Showing results (81-90 of 93) with videos related to
Sort By:
Pageof 10
Journal of Medicinal Chemistry|December 22, 2012
Synthesis, pharmacology, and biostructural characterization of novel α4β2 nicotinic acetylcholine receptor agonistsChristine A Ussing, Camilla P Hansen, Jette G Petersen, et al.Neuropharmacology|January 18, 2015
Engineered α4β2 nicotinic acetylcholine receptors as models for measuring agonist binding and effect at the orthosteric low-affinity α4-α4 interfacePhilip K Ahring, Jeppe A Olsen, Elsebet Ø Nielsen, et al.Molecular Pharmacology|December 15, 2015
Pharmacology and Structural Analysis of Ligand Binding to the Orthosteric Site of Glutamate-Like GluD2 ReceptorsAnders S Kristensen, Kasper B Hansen, Peter Naur, et al.The FEBS Journal|December 25, 2023
Small-molecule positive allosteric modulation of homomeric kainate receptors GluK1-3: development of screening assays and insight into GluK3 structureYasmin Bay, Raminta Venskutonytė, Stine M Frantsen, et al.Journal of Medicinal Chemistry|April 26, 2007
A tetrazolyl-substituted subtype-selective AMPA receptor agonistStine B Vogensen, Karla Frydenvang, Jeremy R Greenwood, et al.Journal of Medicinal Chemistry|April 4, 2019
Use of the 4-Hydroxytriazole Moiety as a Bioisosteric Tool in the Development of Ionotropic Glutamate Receptor LigandsStefano Sainas, Piero Temperini, Jill C Farnsworth, et al.Journal of Medicinal Chemistry|May 31, 2011
Selective kainate receptor (GluK1) ligands structurally based upon 1H-cyclopentapyrimidin-2,4(1H,3H)-dione: synthesis, molecular modeling, and pharmacological and biostructural characterizationRaminta Venskutonyte, Stefania Butini, Salvatore Sanna Coccone, et al.Proceedings of the National Academy of Sciences of the United States of America|February 21, 2012
A high-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1-2 and protects against ischemic brain damageAnders Bach, Bettina H Clausen, Magda Møller, et al.Journal of Medicinal Chemistry|November 7, 2014
Positive allosteric modulators of 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors belonging to 4-cyclopropyl-3,4-dihydro-2h-1,2,4-pyridothiadiazine dioxides and diversely chloro-substituted 4-cyclopropyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxidesPierre Francotte, Ann-Beth Nørholm, Taru Deva, et al.Nature Communications|January 8, 2025
Structural basis of THC analog activity at the Cannabinoid 1 receptorThor S Thorsen, Yashraj Kulkarni, David A Sykes, et al.Pageof 10